24
Participants
Start Date
October 31, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
December 31, 2011
Epivir®, Retrovir® and Viramune®
12 mL of Epivir® (lamivudine) 10 mg/mL solution plus 24 ml of Retrovir® (zidovudine) 10 mg/mL syrup plus and 20 mL of Viramune® (nevirapine) of 10 mg/mL
Lamivudine, Zidovudine and nevirapine
20 mL of reconstituted granules for suspension containing lamivudine 30mg/zidovudine 60 mg/nevirapine 50 mg per 5 mL of suspension
Lamivudine, zidovudine, nevirapine
Lamivudine 30mg/zidovudine 60 mg/nevirapine 50 mg per tablet.
Bowen University Teaching Hospital, Ogbomoso
Lead Sponsor
Elim Pediatric Pharmaceuticals Inc.
OTHER